The Lumera Xpanded Solid Tumor Profile combines next-generation sequencing (NGS) with comprehensive molecular pathology case review and additional testing as needed. NGS analysis covers both DNA sequencing (523 genes) and RNA sequencing (55 genes), as well as copy number variation (CNV), tumor mutational burden (TMB), microsatellite instability (MSI), and RNA fusions and missplicing. Our expert pathology case review will determine complementary IHC, FISH, and molecular assays to be performed in addition to NGS for a fully customized report.
NGS & Pathology testing
10 business days or less
1 FFPE Tumor Block (preferred)
- Include 1 H&E slide if available
- *We also accept core needle biopsies
25 Unstained Slides
- 4-5 micron sections